![John Parselle](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenance du réseau au premier degré de John Parselle
Entité | Type d'entité | Industrie | |
---|---|---|---|
Alcolizer Technology United Kingdom Ltd.
![]() Alcolizer Technology United Kingdom Ltd. Medical DistributorsDistribution Services Alcolizer Technology United Kingdom Ltd. produces drug testing kits. It offers a device used in detecting whether a person in under the influence of specific drugs. The company was founded by Craig Edward Banks and Richard G. Compton on September 26, 2006 and is headquartered in Gateshead, the United Kingdom.
2
| Holding Company | Medical Distributors | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à John Parselle via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
NaturalMotion Ltd.
![]() NaturalMotion Ltd. Packaged SoftwareTechnology Services NaturalMotion Ltd. engages in software solutions and tools. It provides social mobile publisher on IOS and android for games applications. The company was founded on October 15, 2001 and is headquartered in Oxford, The United Kingdom. | Packaged Software | Chairman | |
Helio Display Materials Ltd.
![]() Helio Display Materials Ltd. Miscellaneous Commercial ServicesCommercial Services Helio Display Materials Ltd. engages in research and experimental development on natural sciences and engineering. The company was founded on November 28, 2016 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Oxtex Ltd.
![]() Oxtex Ltd. Medical SpecialtiesHealth Technology Oxtex Ltd. operates as an early-stage medical device company. It develops novel devices for soft tissue expansion. The firm's technology comprises implantable self-inflating tissue expanders available in sizes and shapes to suit the specific needs of the clinician and the patient. The company was founded by Jan Tadeusz Czernuszka and David Edward Jackson in May 2011 and is headquartered in Witney, the United Kingdom. | Medical Specialties | Director/Board Member | |
Chronos Therapeutics Ltd.
![]() Chronos Therapeutics Ltd. BiotechnologyHealth Technology Chronos Therapeutics Ltd. manufactures drugs. It pursuing innovative therapeutics for age-related diseases through the joint efforts of experts in medical research, drug discovery and business development. The company was founded in 2009 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Director/Board Member | |
OBS Medical Ltd.
![]() OBS Medical Ltd. Electronic Equipment/InstrumentsElectronic Technology OBS Medical Ltd. manufactures and distributes physiological monitoring and patient monitoring devices. Its product Visensia, a physiological monitoring system for detecting early clinical patient deterioration. The firm operates as a predictive software company that provides products and services for the hospital, community and consumer health care markets. It develops and support products that enable their customers, both patients and healthcare professionals, to manage and monitor health conditions more effectively through simplification, risk identification and prevention. The company was founded in 2000 and is headquartered in Abingdon, the United Kingdom. | Electronic Equipment/Instruments | Director/Board Member | |
Oxford Spin-out Equity Management
![]() Oxford Spin-out Equity Management Investment ManagersFinance Oxford Spin-out Equity Management (OSEM) is wholly-owned subsidiary of University of Oxford. The firm headquartered at UK. Since 2008, OSEM is responsible for spinout companies. | Investment Managers | Chief Investment Officer | |
Iothic Ltd.
![]() Iothic Ltd. Packaged SoftwareTechnology Services Iothic Ltd. develops machine learning and artificial intelligence applications. The British company was founded in 2017 by Christopher Autry. Christopher Autry has been the CEO since 2017. | Packaged Software | Director/Board Member | |
LabMinds, Inc.
![]() LabMinds, Inc. Packaged SoftwareTechnology Services Part of Accroma Labtec AG, LabMinds, Inc. is a leader in AI and robotics for solution preparation in pharmaceutical and life science labs. The company is based in Somerville, MA. LabMinds' platform addresses the challenges of solution preparation with powerful AI software combined with state-of-the-art robotics to safeguard against tainted inputs, enable near-perfect accuracy, and attain unmatched control. The company was founded in 2008 by Camilla Lisa Oxley, Ville Juhani Lehtonen, Jochen Wilhelm Klingelhoefer, Andrew David Hunt. LabMinds was acquired by Accroma Labtec AG on December 13, 2022. | Packaged Software | Director/Board Member | |
AbFero Pharmaceuticals, Inc.
![]() AbFero Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Abfero Pharmaceuticals, Inc. engages in the development of pharmaceutical products. It develops oral iron chelators for the treatment of diseases of iron-overload. The company was founded by Steven K. Burke, Raymond J. Bergeron, and Thomas X. Neenan and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
Oxford Photovoltaics Ltd.
![]() Oxford Photovoltaics Ltd. Miscellaneous Commercial ServicesCommercial Services Oxford Photovoltaics Ltd. develops and commercialize perovskite-based technology. Its technology can be coated on architectural glass to allow large buildings to generate a significant proportion of their electricity demand, effectively turning them into vertical solar farms. The firm investors include MTI partners, Longwall Venture Partners LLP, Parkwalk, University of Oxford (OSEM). The company was founded by Kevin Arthur and Henry Snaith in December 2010 and is headquartered in Kidlington, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
University of Oxford | College/University | Doctorate Degree | |
Longwall Venture Partners LLP
![]() Longwall Venture Partners LLP Investment ManagersFinance Longwall Venture Partners LLP (Longwall Ventures) is a venture capital firm founded in 2006. The firm is headquartered in Oxford, the United Kingdom. | Investment Managers | Founder | |
MIRRIAD ADVERTISING PLC | Advertising/Marketing Services | Director/Board Member | |
FUTURE PLC | Publishing: Books/Magazines | Director/Board Member | |
Oxford Technology Management Ltd.
![]() Oxford Technology Management Ltd. Investment ManagersFinance Oxford Technology Management Ltd. (Oxford Technology) a venture capital firm founded by Mr. Lucius Cary in 1972. The firm is headquartered in Oxford, UK. | Investment Managers | Private Equity Investor | |
Warwick Effect Polymers Ltd.
![]() Warwick Effect Polymers Ltd. Chemicals: Major DiversifiedProcess Industries Warwick Effect Polymers is engaged in the development and manufacture of novel, high value, and functional polymers using proprietary technologies. The Company was founded in 2001 as a spin-out from the University of Warwick. Its Living Radical Polymerization (LRP) allows precise control over the production of a wide range of complex polymers and has broad applicability in the production of novel specialized polymers for the Pharmaceutical, Biotechnology and Specialty Material industries. WEP's activities are focused in two main business areas: Biopolymers and Specialty Polymers. | Chemicals: Major Diversified | Chairman | |
Morgan Stanley & Co. LLC
![]() Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry. | Investment Banks/Brokers | Corporate Officer/Principal | |
Celleron Therapeutics Ltd.
![]() Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Celleron Therapeutics Ltd. is an oncology company based in Oxford, UK. Celleron has deep relationships with Oxford University and is located on the Oxford Science Park. The British company focuses on the clinical development of new and innovative therapies to treat cancer. Celleron is developing a novel group of clinical products, supported by predictive companion diagnostics, that act through defined molecular mechanisms to prevent cancer cell growth. The company's lead products are currently in clinical trials, and they have a biomarker platform that allows them to identify responsive patients. Celleron Therapeutics Ltd. was founded in 2004, and the CEO is Nick la Thangue. | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
Royaume-Uni | 18 |
Etats-Unis | 4 |
Sectorielle
Health Technology | 6 |
Technology Services | 5 |
Finance | 5 |
Commercial Services | 4 |
Consumer Services | 3 |
Opérationnelle
Director/Board Member | 15 |
Corporate Officer/Principal | 4 |
Chairman | 3 |
Private Equity Investor | 3 |
Founder | 1 |
Relations les plus connectées
Insiders | |
---|---|
Michael Penington | 16 |
Christopher Towler | 6 |
- Bourse
- Insiders
- John Parselle
- Connexions Sociétés